Constellation Brands (STZ)
(Delayed Data from NYSE)
$252.57 USD
+0.86 (0.34%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $252.63 +0.06 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$252.57 USD
+0.86 (0.34%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $252.63 +0.06 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Zacks News
Founded in 1945 and headquartered in Victor, NY, Constellation Brands Inc. produces and markets beer, wine and spirits. It is the third-largest beer company and a leading, high-end wine company in the United States. It has a strong portfolio of high-quality brands, including Corona, Modelo Especial, Robert Mondavi, Kim Crawford, Meiomi and SVEDKA Vodka. The company conducts its operations in the United States, Mexico, Italy and New Zealand.
Monster Beverage (MNST) Q3 Earnings Top, Sales Lag Estimates
by Zacks Equity Research
Monster Beverage (MNST) Q3 results reflect gains from a strong brand performance, innovation, product launches and pricing actions amid elevated logistic and input costs.
Top Stock Reports for Bank of America, AT&T US & Lockheed Martin
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Bank of America Corporation (BAC), AT&T Inc. (T) and Lockheed Martin Corporation (LMT).
Nu Skin (NUS) Dips on Q3 Earnings & Revenue Miss, View Cut
by Zacks Equity Research
Nu Skin's (NUS) third-quarter 2022 results are hurt by higher-than-anticipated macro headwinds, continued inflation, and unfavorable currency. Management lowers the full-year view.
Mondelez (MDLZ) Rises on Q3 Earnings & Sales Beat, View Hike
by Zacks Equity Research
Despite inflation concerns, Mondelez's (MDLZ) Q3 results reflect the resilience of its snacking products and brand strength. Consequently, management raises its 2022 view.
Clorox (CLX) Tops Q1 Earnings & Sales Estimates, Retains View
by Zacks Equity Research
Clorox's (CLX) Q1 results reflect gains from brand strength, strong execution, cost savings and a favorable price mix despite lower volumes.
Molson Coors (TAP) Q3 Earnings Miss Estimates, Sales Beat
by Zacks Equity Research
Molson Coors (TAP) Q3 results reflect gains from solid pricing and a favorable sales mix, offset by consumer inflationary pressures and a strike at its Quebec brewery.
FEMSA (FMX) Earnings Beat Estimates in Q3, Revenues Miss
by Zacks Equity Research
FEMSA (FMX) Q3 results reflect gains from strength across all segments, resulting in top-line growth. Operating income growth and lower interest expenses also aid the results.
Colgate (CL) Q3 Earnings in Line, Higher Costs Hurt Outlook
by Zacks Equity Research
Gains from revenue growth management plans have led to pricing improvements across all regions, aiding Colgate???s (CL) Q3 results. Raw and packaging material, and logistic costs have hurt results.
Newell (NWL) Surpasses Q3 Earnings, Misses Sales Estimates
by Zacks Equity Research
Newell's (NWL) Q3 results reflect the adverse impacts of a tough environment, reduced inventory, inflationary pressures and unfavorable currency. Also, management slashes its 2022 view.
AB InBev (BUD) Tops Q3 Earnings Estimates, Raises EBITDA View
by Zacks Equity Research
AB InBev's (BUD) Q3 results benefit from the continued business momentum, owing to relentless execution, investment in its brands and accelerated digital transformation.
Keurig Dr Pepper (KDP) Q3 Earnings Meet, Sales Lag Estimates
by Zacks Equity Research
Keurig Dr Pepper's (KDP) Q3 results gain from a robust performance in its cold beverages, a recovery in the supply chain of coffee and better pricing. KDP retains its view for 2022.
Coca-Cola (KO) Q3 Earnings & Sales Beat Estimates, Stock Rises
by Zacks Equity Research
Coca-Cola's (KO) Q3 results reflect gains from an improved price/mix, increased concentrate sales and volume growth, which has aided organic sales growth across its segments.
Boston Beer (SAM) Q3 Earnings & Revenues Beat, Stock Rises
by Zacks Equity Research
Boston Beer's (SAM) Q3 results gain from strong pricing, growth in depletions and shipments in Twisted Tea, and the positive results for Hard Mountain Dew.
Procter & Gamble (PG) Shares Rise on Q1 Earnings & Sales Beat
by Zacks Equity Research
Procter & Gamble's (PG) Q1 results reflect gains from robust pricing and a favorable mix, as well as productivity savings, amid cost and currency headwinds.
Why This 1 Consumer Staples Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
PepsiCo (PEP) Tops Q3 Earnings & Sales Estimates, Raises View
by Zacks Equity Research
PepsiCo's (PEP) Q3 results reflect the benefits of strong global beverage and convenient food businesses, improved pricing, and brand investments.
FEMSA (FMX) Concludes Valora Buyout To Expand in Europe
by Zacks Equity Research
FEMSA (FMX) completes the acquisition of all publicly-held registered shares of Valora to strengthen its presence in Europe. It also plans to delist Valora from the SIX Swiss Exchange.
Constellation Brands (STZ) Tops Q2 Earnings & Sales Estimates
by Zacks Equity Research
Constellation Brands' (STZ) Q2 results gain from strong consumer demand for its high-end brands and robust sales growth in the beer business.
Constellation Brands (STZ) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Constellation Brands (STZ) delivered earnings and revenue surprises of 10.07% and 5.57%, respectively, for the quarter ended August 2022. Do the numbers hold clues to what lies ahead for the stock?
Know the Diageo (DEO) Stock In and Out Before Investing
by Zacks Equity Research
Diageo (DEO) looks prim on strong business momentum on continued premiumization efforts and favorable industry trends, particularly in the spirits category.
The Zacks Analyst Blog Highlights NextEra Energy, National Fuel Gas, General Mills, Constellation Brands and Molina Healthcare
by Zacks Equity Research
NextEra Energy, National Fuel Gas, General Mills, Constellation Brands and Molina Healthcare are part of The Zacks top Analyst Blog.
Defensive Sectors Likely to Shine for the Rest of 2022
by Nalak Das
We have selected five defensive stocks for the rest of 2022. These are: NEE, NFG, GIS, STZ and MOH.
FedEx, Nike, Micron, Conagra and Constellation Brands are part of Zacks Earnings Preview
by Zacks Equity Research
FedEx, Nike, Micron, Conagra and Constellation Brands are part of Zacks Earnings Preview.
Previewing Q3 Earnings Season After Rough Reports from Nike and Micron
by Sheraz Mian
We are starting to look at these early reports from FedEx, Nike, Micron and others for their fiscal periods ending in August as giving us a preview of what likely lies ahead as the banks kick-off the Q3 reporting cycle in about two weeks
How Constellation Brands (STZ) is Placed Ahead of Q2 Earnings
by Zacks Equity Research
Constellation Brands' (STZ) Q2 results to reflect continued gains from strong demand for its premium portfolio and strength in the beer business amid rising costs and supply-chain challenges.